INVENTIVA: Inventiva announces the schedule of publication and presentation of its 2021 Full-Year Financial Results
Daix (France), Long Island City (New York, United States), February 28, 2022 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral